raloxifene hydrochloride has been researched along with Sensitivity and Specificity in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 13 (76.47) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Kanis, JA; Kim, K; Luo, X; Sutradhar, S; Svedbom, A | 1 |
| Pávó, I; Pósa, A; Varga, C | 1 |
| Banie, L; Lin, CS; Lin, G; Lue, TF; Ning, H; Wang, G | 1 |
| Alencar, AP; da Silva, BB; de Castro-Leão, AH; dos Santos, AR; Lopes-Costa, PV; Pires, CG | 1 |
| Heath, H; Merritt, D; Parsons, A; Plouffe, L; Rosen, A; Siddhanti, S | 1 |
| Ablondi, F; Bacchi-Modena, A; Baldini, M; Bertone, L; Ceda, GP; Ceresini, G; Denti, L; Marchini, L; Montanari, I; Morganti, S; Rebecchi, I; Sgarabotto, M; Valenti, G | 1 |
| de Jong, S; Neele, SJ; Netelenbos, JC; Stehouwer, CD; Teerlink, T | 1 |
| Ascaso, C; Blümel, JE; Casals, E; Castelo-Branco, C; Colodrón, M; Escaramís, G; Mercader, I; Ordi, J; Sanjuán, A; Vanrell, JA; Vicente, JJ | 1 |
| Eng-Wong, J; Hursting, SD; Perkins, SN; Venzon, D; Zujewski, JA | 1 |
| Baracat, EC; de Deus, JM; Dietrich, CP; Girão, MJ; Nader, HB; Rodrigues de Lima, G; Sartori, MG | 1 |
| He, X; Yang, Z; Zhang, Y | 1 |
| He, YQ; Kong, L; Liu, SP; Liu, ZF; Lu, QM | 1 |
| Lane, MV; Merchenthaler, I; Shughrue, PJ | 1 |
| Col, NF; Eckman, MH; Goldberg, RJ; Orr, RK; Pauker, SG; Ross, EM; Wong, JB | 1 |
| Drewry, DH; Henke, BR; Jones, SA; Stewart, EL; Weaver, SL; Wiethe, RW | 1 |
| Neven, P; Vergote, I | 1 |
1 review(s) available for raloxifene hydrochloride and Sensitivity and Specificity
| Article | Year |
|---|---|
Tamoxifen, screening and new oestrogen receptor modulators.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endosonography; Female; Humans; Hysteroscopy; Mass Screening; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity; Tamoxifen | 2001 |
4 trial(s) available for raloxifene hydrochloride and Sensitivity and Specificity
| Article | Year |
|---|---|
Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
Topics: Administration, Intravaginal; Adult; Aged; Aged, 80 and over; Atrophy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Middle Aged; Postmenopause; Probability; Raloxifene Hydrochloride; Reference Values; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Vagina; Vaginal Creams, Foams, and Jellies; Vaginal Diseases | 2003 |
Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women.
Topics: Aged; Blood Flow Velocity; Carotid Arteries; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Estrogen Antagonists; Female; Humans; Middle Aged; Postmenopause; Probability; Raloxifene Hydrochloride; Reference Values; Sensitivity and Specificity; Vascular Resistance; Vasodilation | 2003 |
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
Topics: Analysis of Variance; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Middle Aged; Nitric Oxide Synthase; Postmenopause; Protein Isoforms; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity | 2003 |
Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Topics: Administration, Oral; Adult; Age Factors; Biomarkers, Tumor; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Leptin; Middle Aged; Pilot Projects; Premenopause; Probability; Raloxifene Hydrochloride; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric | 2003 |
12 other study(ies) available for raloxifene hydrochloride and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm.
Topics: Aged; Algorithms; Bone Density Conservation Agents; Cost-Benefit Analysis; Decision Support Techniques; Dose-Response Relationship, Drug; Europe; Female; Health Care Costs; Health Services Research; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality of Life; Raloxifene Hydrochloride; Risk Assessment; Sensitivity and Specificity | 2014 |
Heme oxygenase contributes to estradiol and raloxifene-induced vasorelaxation in estrogen deficiency.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Estradiol; Estrogens; Female; Heme Oxygenase (Decyclizing); Ovariectomy; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Wistar; Sensitivity and Specificity; Vasodilation | 2015 |
Effects of estrogen, raloxifene and levormeloxifene on alpha1A-adrenergic receptor expression.
Topics: Animals; Blotting, Western; Disease Models, Animal; Down-Regulation; Estrogens; Female; Fluorescent Antibody Technique; Gene Expression Regulation; Immunohistochemistry; Postpartum Period; Pregnancy; Pregnancy, Animal; Pyrrolidines; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity | 2008 |
Effects of raloxifene on Ki-67 and CD34 antigen expression in breast cancer.
Topics: Adult; Aged; Antigens, CD34; Biomarkers; Biopsy, Needle; Breast Neoplasms; Cohort Studies; Female; Follow-Up Studies; Humans; Immunohistochemistry; Ki-67 Antigen; Mastectomy, Segmental; Microvessels; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neovascularization, Pathologic; Observer Variation; Preoperative Care; Probability; Raloxifene Hydrochloride; Receptors, Estrogen; Reference Values; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2009 |
Raloxifene inhibits cholesterol aortic content but not atherosclerotic plaque size in oophorectomised cholesterol-fed rabbits.
Topics: Analysis of Variance; Animals; Aorta; Area Under Curve; Arteriosclerosis; Biopsy, Needle; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Female; Immunohistochemistry; Lipoproteins, LDL; Ovariectomy; Probability; Rabbits; Raloxifene Hydrochloride; Random Allocation; Reference Values; Selective Estrogen Receptor Modulators; Sensitivity and Specificity | 2004 |
Glycosaminoglycan profile in bladder and urethra of castrated rats treated with estrogen, progestogen, and raloxifene.
Topics: Analysis of Variance; Animals; Biomarkers; Disease Models, Animal; Electrophoresis, Agar Gel; Estrogens; Female; Glycosaminoglycans; Ovariectomy; Probability; Progesterone; Raloxifene Hydrochloride; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Urethra; Urinary Bladder | 2003 |
The determination of raloxifene in rat tissue using HPLC.
Topics: Animals; Chromatography, High Pressure Liquid; Molecular Structure; Raloxifene Hydrochloride; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tissue Distribution | 2007 |
Resonance Rayleigh scattering spectral method for the determination of raloxifene using gold nanoparticle as a probe.
Topics: Gold; Metal Nanoparticles; Raloxifene Hydrochloride; Scattering, Radiation; Sensitivity and Specificity; Spectrum Analysis | 2007 |
Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study.
Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; In Situ Hybridization; Piperidines; Preoptic Area; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; RNA, Messenger; Sensitivity and Specificity; Tamoxifen; Time Factors | 1997 |
Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.
Topics: Alendronate; Bone Density; Breast Neoplasms; Coronary Disease; Decision Support Techniques; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Life Expectancy; Lipids; Markov Chains; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Postmenopause; Raloxifene Hydrochloride; Risk; Risk Factors; Sensitivity and Specificity | 1999 |
2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor.
Topics: Bacteria; Binding Sites; Crystallography, X-Ray; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Ligands; Protein Binding; Pyridines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Sensitivity and Specificity | 2001 |